Senior insider sale
Chief Development Officer at RAPPORT THERAPEUTICS, INC. — senior position signals high conviction
$371.1K
12.96K shares
What this filing means
YELESWARAM KRISHNASWAMY plans to sell 12.96K shares of RAPPORT THERAPEUTICS, INC. valued at approximately $371.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/25/2026ACC: 0001950047-26-002990
Officer· Chief Development Officer
Since Feb 2026
12.96K
Shares to sell
$371.1K
Approx. market value
10.12K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Founders Shares
N/A
5/20/2025
10.12KTotal acquired10.12K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/20/2025 | Founders Shares N/A | 10.12K | — |
| Total | 10.12K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.84K
Market value
$85.3K
12/31/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
10.12K
Market value
$285.7K
3/25/2026
Total
Units
12.96K
Value
$371.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/31/2025 | 2.84K | $85.3K | — | Completed |
| Planned — Approximate Date | ||||
3/25/2026 | 10.12K | $285.7K | NASDAQ | Planned |
| Total | 12.96K | $371.1K | ||